• About Us
    • Contact Us
    • Login
    • ObGFirst
  • Alerts
  • OB
  • 2T US Atlas
  • The Genome
  • GYN
    • GYN
    • Sexual Health
  • Primary Care
  • Your Practice
  • GrandRounds
  • My Bookshelf
  • COVID-19
About Us Contact Us Login ObGFirst
  • Alerts
  • OB
  • 2T US Atlas
  • The Genome
  • GYN
    • GYN
    • Sexual Health
  • Primary Care
  • Your Practice
  • GrandRounds
  • My Bookshelf
  • COVID-19
Primary Care

Bell’s Palsy: Clinical Presentation and Treatment

image_pdfFavoriteLoadingFavorite

SUMMARY:

Bell’s palsy is a temporary facial weakness or paralysis resulting from dysfunction of the VIIth cranial nerve. It almost always presents as rapid unilateral facial nerve paralysis which leads to partial or complete loss of voluntary facial muscle movement. It can also lead to oral incompetence and incomplete closure of the eyelid (lagopthalmos) which predisposes to eye injury. Bell’s palsy is the most common cause of unilateral facial paralysis affecting nearly 40,000 people in the US every year.  While the precise cause is unknown, onset is often related to viral infection (e.g., flu, adenoviruses, CMV, herpes simplex, herpes zoster)

KEY POINTS:

Clinical Presentation

  • Unilateral facial nerve paralysis
    • There is loss of facial creases and nasolabial fold
    • Forehead unfurrows
    • Corner of the mouth droops
    • Eyelids cannot close and the lower lid sags
    • Bell’s phenomenon: When an attempt is made to close the eye, the eye rolls upward
  • NOTE: If the patient can furrow their brow, suspect central lesion because of dual innervation to the  1st branch of the facial nerve
  • Rapid onset: Usually 72 hours from onset to maximum weakness
  • Common age group: 15 to 45 years (both men and women)
  • Pain: May be associated with ipsilateral pain surrounding the ear and face
  • Differential (facial paralysis)
    • Systemic and infectious diseases: Lyme disease, sarcoidosis, zoster
    • CNS: Tumors, CVA
    • Non-CNS tumors: Parotid gland, infratemporal fossa, cancer involving the facial nerve
Facial Nerve Lesion (Bell’s Palsy) vs Central Facial Palsy

Risk Factors

  • Pregnancy has been associated with Bell’s palsy
    • Also associated with severe preeclampsia
  • Obesity
  • Hypertension
  • Diabetes
  • Upper respiratory ailments

Testing

  • There is no indication for routine laboratory testing
  • Based on the clinical setting, Lyme disease can account for up to 25% of cases and serologies may be helpful
  • Routine use of brain imaging is not recommended
    • However, if paralysis is inconsistent with Bell’s palsy, consider imaging to rule out CNS and other potential masses and lesions

Treatment

  • Prednisone is recommended if started in 72 hours for patients ≥16 years
    • 50 to 60 mg daily for total of 10 days | Full dose for the first 5 days then taper over the next 5 days
    • Acyclovir or valacyclovir is optional to start and use together with steroids
  • Eye protection
    • Can use eye patching or taping to prevent corneal abrasions, keratitis, and ulcerations

Follow-Up

  • 85% of patients show partial recovery within three weeks of onset
  • Complete recovery occurs in 70% of patients in 6 months
  • Refer to specialist if
    • New or worsening neurologic symptoms appear at any time
    • Incomplete resolution at 3 months
    • Ocular complications

Learn More – Primary Sources:

American Academy of Otolaryngology Head and Neck Surgery Foundation Clinical practice guideline: Bell’s palsy

BMJ: Bell’s Palsy

Now You Can Get ObG Clinical Research Summaries Direct to Your Phone, with ObGFirst

ObGFirst® – Try It Free! »

image_pdfFavoriteLoadingFavorite
< Previous
All Primary Care Posts
Next >

Related ObG Topics:

Herpes Zoster: Clinical Presentation and Treatment
Lyme Disease: Diagnosis and Treatment
Cochrane Review Update: Does Adding Antivirals to Corticosteroid Treatment for Bell’s Palsy Add Benefit?

Sections

  • Alerts
  • OB
  • GYN
    • GYN
    • Sexual Health
  • 2T US Atlas
  • The Genome
  • Primary Care
  • Your Practice
  • Grand Rounds
  • My Bookshelf
  • COVID-19

Are you an
ObG Insider?

Get specially curated clinical summaries delivered to your inbox every week for free

  • Site Map/
  • © ObG Project/
  • Terms and Conditions/
  • Privacy/
  • Contact Us/
© ObG Project
SSL Certificate


  • Already an ObGFirst Member?
    Welcome back

    Log In

    Want to sign up?
    Get guideline notifications
    CME Included

    Sign Up

Sign In

Lost your password?

Sign Up for ObGFirst and Stay Ahead

  • - Professional guideline notifications
  • - Daily summary of a clinically relevant
    research paper
  • - Includes 1 hour of CME every month

ObGFirst Free Trial

Already a Member of ObGFirst®?

Please log in to ObGFirst to access the 2T US Atlas

Password Trouble?

Not an ObGFirst® Member Yet?

  • - Access 2T US Atlas
  • - Guideline notifications
  • - Daily research paper summaries
  • - And lots more!
ObGFirst Free Trial

Media - Internet

Computer System Requirements

OBG Project CME requires a modern web browser (Internet Explorer 10+, Mozilla Firefox, Apple Safari, Google Chrome, Microsoft Edge). Certain educational activities may require additional software to view multimedia, presentation, or printable versions of their content. These activities will be marked as such and will provide links to the required software. That software may be: Adobe Flash, Apple QuickTime, Adobe Acrobat, Microsoft PowerPoint, Windows Media Player, or Real Networks Real One Player.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information
presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Jointly provided by

NOT ENOUGH CME HOURS

It appears you don't have enough CME Hours to take this Post-Test. Feel free to buy additional CME hours or upgrade your current CME subscription plan

Subscribe

JOIN OBGFIRST AND GET CME/CE CREDITS

One of the benefits of an ObGFirst subscription is the ability to earn CME/CE credits from the ObG entries you read. Tap the button to learn more about ObGFirst

Learn More
Leaving ObG Website

You are now leaving the ObG website and on your way to PRIORITY at UCSF, an independent website. Therefore, we are not responsible for the content or availability of this site